Siglec15 is a prognostic indicator and a potential tumor-related macrophage regulator that is involved in the suppressive immunomicroenvironment in gliomas

BACKGROUND: Siglec15 is rising as a promising immunotherapeutic target in bladder, breast, gastric, and pancreatic cancers. The aim of the present study is to explore the prognostic value and immunotherapeutic possibilities of Siglec15 in gliomas using bioinformatics and clinicopathological methods....

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jinchao, Xu, Linzong, Ding, Qian, Li, Xiaoru, Wang, Kai, Xu, Shangchen, Liu, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266207/
https://www.ncbi.nlm.nih.gov/pubmed/37325664
http://dx.doi.org/10.3389/fimmu.2023.1065062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266207/
https://www.ncbi.nlm.nih.gov/pubmed/37325664
http://dx.doi.org/10.3389/fimmu.2023.1065062

Ejemplares similares